Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
Clinical trial NCT07431086 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07431086
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2026-11-13
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.